Literature DB >> 23221900

Dietary ω-3 deficiency and IOP insult are additive risk factors for ganglion cell dysfunction.

Christine T O Nguyen1, Algis J Vingrys, Bang V Bui.   

Abstract

AIM: Dietary deficiencies in ω-3 polyunsaturated fatty acids are known to effect retinal function including retinal ganglion cell (RGC) activity, which may have implications for glaucoma. In this study we consider retinal function after dietary manipulation and intraocular pressure (IOP) stress designed to compromise RGCs.
METHODS: Sprague-Dawley dams were fed either ω-3 sufficient (ω-3, n=15) or deficient (ω-3, n=16) diets 5 weeks before conception with pups subsequently weaned onto their mothers diets. At 20 weeks of age, acute IOP elevation was induced repeatedly through anterior chamber cannulation to 70 mm Hg for 1 hour on 3 separate occasions separated by 1 week. Electroretinograms were recorded 1 week after each IOP elevation to assay the photoreceptors (PIII), ON-bipolar cells (PII), and ganglion/amacrine cells (STR).
RESULTS: Repeat IOP insult results in a specific RGC dysfunction (pSTR -14.5%, P<0.035) as does ω-3 deficiency (-26.4%, P<0.01). However, the combination of both causes an even larger RGC functional loss (-40.1%, P<0.001) than does either diet or IOP insult in isolation (P<0.001).
CONCLUSIONS: Both ω-3 deficiency and repeat acute IOP insult cause RGC dysfunction and the combination of these factors results in a cumulative effect. Our data indicate that sufficient dietary ω-3 improves RGC function making it less susceptible to IOP insult.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23221900     DOI: 10.1097/IJG.0b013e318237cac7

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  6 in total

Review 1.  Astrocyte polarization in glaucoma: a new opportunity.

Authors:  Yi-Xin Liu; Hao Sun; Wen-Yi Guo
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

2.  Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial.

Authors:  Stéphanie Romeo Villadóniga; Elena Rodríguez García; Olatz Sagastagoia Epelde; M Dolores Álvarez Díaz; Joan Carles Domingo Pedrol
Journal:  J Ophthalmol       Date:  2018-09-17       Impact factor: 1.909

3.  Plasma fatty acids and primary open-angle glaucoma in the elderly: the Montrachet population-based study.

Authors:  Alicia Chemaly; Louis Arnould; Alassane Seydou; Pierre-Henry Gabrielle; Florian Baudin; Niyazi Acar; Catherine Creuzot-Garcher
Journal:  BMC Ophthalmol       Date:  2021-03-23       Impact factor: 2.209

Review 4.  Rational Basis for Nutraceuticals in the Treatment of Glaucoma.

Authors:  Luigi Antonio Morrone; Laura Rombola; Annagrazia Adornetto; Maria Tiziana Corasaniti; Rossella Russo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 5.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma.

Authors:  Annagrazia Adornetto; Laura Rombolà; Luigi Antonio Morrone; Carlo Nucci; Maria Tiziana Corasaniti; Giacinto Bagetta; Rossella Russo
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

Review 6.  Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review.

Authors:  María Lafuente; María Elena Rodríguez González-Herrero; Stéphanie Romeo Villadóniga; Joan Carles Domingo
Journal:  Antioxidants (Basel)       Date:  2021-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.